lidocaine has been researched along with Headache Disorders in 16 studies
Lidocaine: A local anesthetic and cardiac depressant used as an antiarrhythmia agent. Its actions are more intense and its effects more prolonged than those of PROCAINE but its duration of action is shorter than that of BUPIVACAINE or PRILOCAINE.
lidocaine : The monocarboxylic acid amide resulting from the formal condensation of N,N-diethylglycine with 2,6-dimethylaniline.
Headache Disorders: Various conditions with the symptom of HEADACHE. Headache disorders are classified into major groups, such as PRIMARY HEADACHE DISORDERS (based on characteristics of their headache symptoms) and SECONDARY HEADACHE DISORDERS (based on their etiologies). (International Classification of Headache Disorders, 2nd ed. Cephalalgia 2004: suppl 1)
| Excerpt | Relevance | Reference |
|---|---|---|
| "Open label and retrospective studies have investigated the use of lidocaine in many headache disorders, primarily via injection or infusion." | 8.98 | The Use and Method of Action of Intravenous Lidocaine and Its Metabolite in Headache Disorders. ( Berk, T; Silberstein, SD, 2018) |
| "Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) is a primary headache syndrome that has been reported to be resistant to treatment with intravenous lidocaine." | 7.72 | SUNCT syndrome responsive to intravenous lidocaine. ( Cohen, AS; Goadsby, PJ; Matharu, MS, 2004) |
| "Open label and retrospective studies have investigated the use of lidocaine in many headache disorders, primarily via injection or infusion." | 4.98 | The Use and Method of Action of Intravenous Lidocaine and Its Metabolite in Headache Disorders. ( Berk, T; Silberstein, SD, 2018) |
| "This service evaluation reviewed greater occipital nerve injections performed unilaterally with 30 mg 1% lidocaine and 40 mg methylprednisolone, to treat disabling headache disorders in children and adolescents." | 3.88 | Treatment of disabling headache with greater occipital nerve injections in a large population of childhood and adolescent patients: a service evaluation. ( Goadsby, PJ; Prabhakar, P; Puledda, F, 2018) |
| "Short-lasting unilateral neuralgiform headache with conjunctival injection and tearing (SUNCT) is a primary headache syndrome that has been reported to be resistant to treatment with intravenous lidocaine." | 3.72 | SUNCT syndrome responsive to intravenous lidocaine. ( Cohen, AS; Goadsby, PJ; Matharu, MS, 2004) |
| "Lidocaine was associated with significantly higher rates of adverse events compared with placebo and may result in lower rates of patient satisfaction." | 2.58 | Intranasal Lidocaine for Acute Management of Primary Headaches: A Systematic Review. ( Dagenais, R; Zed, PJ, 2018) |
| "In two patients with intractable headache, the daily maximum intensity of headache (graded by 11-point numeric rating scale) was recorded for 7 days postprocedure." | 1.62 | Intra-arterial injection of lidocaine into middle meningeal artery to treat intractable headaches and severe migraine. ( Babar, S; French, BR; Gomez, CR; Huang, W; Ishfaq, MF; Lobanova, I; Pfeiffer, K; Qureshi, AI; Siddiq, F, 2021) |
| " Dosing regimens, volumes of injection, and injection schedules varied greatly." | 1.36 | Patterns of use of peripheral nerve blocks and trigger point injections among headache practitioners in the USA: Results of the American Headache Society Interventional Procedure Survey (AHS-IPS). ( Ashkenazi, A; Blumenfeld, A; DePalma, T; Grosberg, B; Lipton, RB; Napchan, U; Narouze, S; Nett, B; Rosenthal, B; Tepper, S, 2010) |
| "Lidocaine infusion was generally well tolerated with a low incidence of adverse events leading to discontinuation of treatment." | 1.35 | Intravenous lidocaine in the treatment of refractory headache: a retrospective case series. ( Abbas, M; Marmura, M; Rosen, N; Silberstein, S, 2009) |
| "The pathophysiology of many types of chronic headaches is not well understood." | 1.33 | Cervicogenic headache in patients with presumed migraine: missed diagnosis or misdiagnosis? ( Cook, AJ; Hamill-Ruth, RJ; Rowlingson, JC; Yi, X, 2005) |
| "His headaches fit the IHS criteria for cluster headache but had some irregularities including frequent side shifting of pain, irregular duration and time of onset and the ability of the patient to sit completely still during a headache without any sense of agitation." | 1.33 | Non-hypothalamic cluster headache: the role of the greater occipital nerve in cluster headache pathogenesis. ( Rozen, TD, 2005) |
| "Patients with chronic daily headache with medication overuse are difficult to treat, especially when the doses of analgesia are substantial." | 1.32 | Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse. ( Stark, RJ; Williams, DR, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 9 (56.25) | 29.6817 |
| 2010's | 5 (31.25) | 24.3611 |
| 2020's | 2 (12.50) | 2.80 |
| Authors | Studies |
|---|---|
| Digala, LP | 1 |
| Lucchese, S | 1 |
| Qureshi, AI | 1 |
| Pfeiffer, K | 1 |
| Babar, S | 1 |
| Huang, W | 1 |
| Lobanova, I | 1 |
| Ishfaq, MF | 1 |
| French, BR | 1 |
| Siddiq, F | 1 |
| Gomez, CR | 1 |
| Puledda, F | 1 |
| Goadsby, PJ | 3 |
| Prabhakar, P | 1 |
| Berk, T | 1 |
| Silberstein, SD | 1 |
| Dagenais, R | 1 |
| Zed, PJ | 1 |
| Farmer, RL | 1 |
| Garg, RK | 1 |
| Afifi, AM | 1 |
| de Ru, JA | 1 |
| Buwalda, J | 1 |
| Rosen, N | 1 |
| Marmura, M | 1 |
| Abbas, M | 1 |
| Silberstein, S | 1 |
| Rozen, TD | 2 |
| Blumenfeld, A | 1 |
| Ashkenazi, A | 1 |
| Grosberg, B | 1 |
| Napchan, U | 1 |
| Narouze, S | 1 |
| Nett, B | 1 |
| DePalma, T | 1 |
| Rosenthal, B | 1 |
| Tepper, S | 1 |
| Lipton, RB | 1 |
| Linetsky, FS | 1 |
| Miguel, R | 1 |
| Torres, F | 1 |
| Williams, DR | 1 |
| Stark, RJ | 1 |
| Matharu, MS | 1 |
| Cohen, AS | 1 |
| Shields, KG | 1 |
| Levy, MJ | 1 |
| Yi, X | 1 |
| Cook, AJ | 1 |
| Hamill-Ruth, RJ | 1 |
| Rowlingson, JC | 1 |
4 reviews available for lidocaine and Headache Disorders
| Article | Year |
|---|---|
The Use and Method of Action of Intravenous Lidocaine and Its Metabolite in Headache Disorders.
Topics: Anesthetics; Headache Disorders; Humans; Lidocaine | 2018 |
Intranasal Lidocaine for Acute Management of Primary Headaches: A Systematic Review.
Topics: Administration, Intranasal; Anesthetics, Local; Headache Disorders; Humans; Lidocaine; Patient Satis | 2018 |
Can Functional Nasal Surgery Treat Chronic Headaches? A Systematic Review.
Topics: Anesthetics, Local; Chronic Disease; Endoscopy; Headache Disorders; Humans; Lidocaine; Pain Measurem | 2018 |
Treatment of cervicothoracic pain and cervicogenic headaches with regenerative injection therapy.
Topics: Cervical Vertebrae; Clinical Trials as Topic; Collagen; Connective Tissue Diseases; Glucose; Glycero | 2004 |
12 other studies available for lidocaine and Headache Disorders
| Article | Year |
|---|---|
IV Lidocaine Infusion Leading to the Toxic Levels in Serum Causing Asystole - A Case Report.
Topics: Anesthetics; Depressive Disorder; Drug Interactions; Female; Headache Disorders; Heart Arrest; Human | 2020 |
Intra-arterial injection of lidocaine into middle meningeal artery to treat intractable headaches and severe migraine.
Topics: Headache Disorders; Humans; Injections, Intra-Arterial; Lidocaine; Meningeal Arteries; Migraine Diso | 2021 |
Treatment of disabling headache with greater occipital nerve injections in a large population of childhood and adolescent patients: a service evaluation.
Topics: Adolescent; Child; Female; Headache Disorders; Headache Disorders, Primary; Humans; Lidocaine; Male; | 2018 |
Botulinum toxin A injection into corrugator muscle for frontally localised chronic daily headache or chronic tension-type headache.
Topics: Adolescent; Adult; Anesthetics, Local; Botulinum Toxins, Type A; Facial Muscles; Facial Pain; Female | 2009 |
Intravenous lidocaine in the treatment of refractory headache: a retrospective case series.
Topics: Adolescent; Adult; Aged; Anesthetics, Local; Female; Headache Disorders; Humans; Infusions, Intraven | 2009 |
Intranasal contact point headache: missing the "point" on brain MRI.
Topics: Anesthetics, Local; Female; Headache Disorders; Humans; Lidocaine; Magnetic Resonance Imaging; Male; | 2009 |
Patterns of use of peripheral nerve blocks and trigger point injections among headache practitioners in the USA: Results of the American Headache Society Interventional Procedure Survey (AHS-IPS).
Topics: Anesthetics, Local; Bupivacaine; Cross-Sectional Studies; Headache; Headache Disorders; Health Care | 2010 |
Intravenous lignocaine (lidocaine) infusion for the treatment of chronic daily headache with substantial medication overuse.
Topics: Adolescent; Adult; Aged; Analgesics; Clinical Trials as Topic; Female; Headache Disorders; Humans; I | 2003 |
SUNCT syndrome responsive to intravenous lidocaine.
Topics: Conjunctiva; Female; Headache Disorders; Humans; Infusions, Intravenous; Lidocaine; Male; Middle Age | 2004 |
Alopecia and cutaneous atrophy after greater occipital nerve infiltration with corticosteroid.
Topics: Adipose Tissue; Adult; Alopecia; Anesthesia, Local; Anesthetics, Local; Atrophy; Female; Headache Di | 2004 |
Cervicogenic headache in patients with presumed migraine: missed diagnosis or misdiagnosis?
Topics: Adult; Aged; Anesthetics, Local; Bupivacaine; Cervical Plexus; Cervical Vertebrae; Chronic Disease; | 2005 |
Non-hypothalamic cluster headache: the role of the greater occipital nerve in cluster headache pathogenesis.
Topics: Afferent Pathways; Anesthetics, Local; Anti-Inflammatory Agents; Anticonvulsants; Circadian Rhythm; | 2005 |